GLOBAL CAR-T CELLULAR IMMUNOTHERAPY MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Sep 2021 75
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of CAR-T Cellular Immunotherapy
1.2 Classification of CAR-T Cellular Immunotherapy by Type
1.2.1 Overview: Global CAR-T Cellular Immunotherapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global CAR-T Cellular Immunotherapy Revenue Market Share by Type in 2020
1.2.3 Allogeneic
1.2.4 Autologous
1.3 Global CAR-T Cellular Immunotherapy Market by Application
1.3.1 Overview: Global CAR-T Cellular Immunotherapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global CAR-T Cellular Immunotherapy Market Size & Forecast
1.5 Global CAR-T Cellular Immunotherapy Market Size and Forecast by Region
1.5.1 Global CAR-T Cellular Immunotherapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global CAR-T Cellular Immunotherapy Market Size by Region, (2016-2021)
1.5.3 North America CAR-T Cellular Immunotherapy Market Size and Prospect (2016-2026)
1.5.4 Europe CAR-T Cellular Immunotherapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific CAR-T Cellular Immunotherapy Market Size and Prospect (2016-2026)
1.5.6 South America CAR-T Cellular Immunotherapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa CAR-T Cellular Immunotherapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 CAR-T Cellular Immunotherapy Market Drivers
1.6.2 CAR-T Cellular Immunotherapy Market Restraints
1.6.3 CAR-T Cellular Immunotherapy Trends Analysis
2 Company Profiles
2.1 Fosun Kite Biotechnology
2.1.1 Fosun Kite Biotechnology Details
2.1.2 Fosun Kite Biotechnology Major Business
2.1.3 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product and Solutions
2.1.4 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Fosun Kite Biotechnology Recent Developments and Future Plans
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences CAR-T Cellular Immunotherapy Product and Solutions
2.2.4 Gilead Sciences CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Gilead Sciences Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis CAR-T Cellular Immunotherapy Product and Solutions
2.3.4 Novartis CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product and Solutions
2.4.4 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global CAR-T Cellular Immunotherapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 CAR-T Cellular Immunotherapy Players Market Share
3.2.2 Top 10 CAR-T Cellular Immunotherapy Players Market Share
3.2.3 Market Competition Trend
3.3 CAR-T Cellular Immunotherapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global CAR-T Cellular Immunotherapy Revenue and Market Share by Type (2016-2021)
4.2 Global CAR-T Cellular Immunotherapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global CAR-T Cellular Immunotherapy Revenue Market Share by Application (2016-2021)
5.2 CAR-T Cellular Immunotherapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America CAR-T Cellular Immunotherapy Revenue by Type (2016-2026)
6.2 North America CAR-T Cellular Immunotherapy Revenue by Application (2016-2026)
6.3 North America CAR-T Cellular Immunotherapy Market Size by Country
6.3.1 North America CAR-T Cellular Immunotherapy Revenue by Country (2016-2026)
6.3.2 United States CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
6.3.3 Canada CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
6.3.4 Mexico CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe CAR-T Cellular Immunotherapy Revenue by Type (2016-2026)
7.2 Europe CAR-T Cellular Immunotherapy Revenue by Application (2016-2026)
7.3 Europe CAR-T Cellular Immunotherapy Market Size by Country
7.3.1 Europe CAR-T Cellular Immunotherapy Revenue by Country (2016-2026)
7.3.2 Germany CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
7.3.3 France CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
7.3.5 Russia CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
7.3.6 Italy CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Type (2016-2026)
8.2 Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Application (2016-2026)
8.3 Asia-Pacific CAR-T Cellular Immunotherapy Market Size by Region
8.3.1 Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Region (2016-2026)
8.3.2 China CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8.3.3 Japan CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8.3.4 South Korea CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8.3.5 India CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8.3.7 Australia CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America CAR-T Cellular Immunotherapy Revenue by Type (2016-2026)
9.2 South America CAR-T Cellular Immunotherapy Revenue by Application (2016-2026)
9.3 South America CAR-T Cellular Immunotherapy Market Size by Country
9.3.1 South America CAR-T Cellular Immunotherapy Revenue by Country (2016-2026)
9.3.2 Brazil CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
9.3.3 Argentina CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Type (2016-2026)
10.2 Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Application (2016-2026)
10.3 Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Country
10.3.1 Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Country (2016-2026)
10.3.2 Turkey CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
10.3.4 UAE CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global CAR-T Cellular Immunotherapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global CAR-T Cellular Immunotherapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market CAR-T Cellular Immunotherapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global CAR-T Cellular Immunotherapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global CAR-T Cellular Immunotherapy Revenue Market Share by Region (2021-2026)
Table 6. Fosun Kite Biotechnology Corporate Information, Head Office, and Major Competitors
Table 7. Fosun Kite Biotechnology Major Business
Table 8. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product and Solutions
Table 9. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 11. Gilead Sciences Major Business
Table 12. Gilead Sciences CAR-T Cellular Immunotherapy Product and Solutions
Table 13. Gilead Sciences CAR-T Cellular Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis CAR-T Cellular Immunotherapy Product and Solutions
Table 17. Novartis CAR-T Cellular Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 19. Bristol-Myers Squibb Major Business
Table 20. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product and Solutions
Table 21. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global CAR-T Cellular Immunotherapy Revenue (USD Million) by Players (2019-2021)
Table 23. Global CAR-T Cellular Immunotherapy Revenue Share by Players (2019-2021)
Table 24. Breakdown of CAR-T Cellular Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. CAR-T Cellular Immunotherapy Players Head Office, Products and Services Provided
Table 26. CAR-T Cellular Immunotherapy Mergers & Acquisitions in the Past Five Years
Table 27. CAR-T Cellular Immunotherapy New Entrants and Expansion Plans
Table 28. Global CAR-T Cellular Immunotherapy Revenue (USD Million) by Type (2016-2021)
Table 29. Global CAR-T Cellular Immunotherapy Revenue Share by Type (2016-2021)
Table 30. Global CAR-T Cellular Immunotherapy Revenue Forecast by Type (2021-2026)
Table 31. Global CAR-T Cellular Immunotherapy Revenue by Application (2016-2021)
Table 32. Global CAR-T Cellular Immunotherapy Revenue Forecast by Application (2021-2026)
Table 33. North America CAR-T Cellular Immunotherapy Revenue by Type (2016-2021) & (USD Million)
Table 34. North America CAR-T Cellular Immunotherapy Revenue by Type (2021-2026) & (USD Million)
Table 35. North America CAR-T Cellular Immunotherapy Revenue by Application (2016-2021) & (USD Million)
Table 36. North America CAR-T Cellular Immunotherapy Revenue by Application (2021-2026) & (USD Million)
Table 37. North America CAR-T Cellular Immunotherapy Revenue by Country (2016-2021) & (USD Million)
Table 38. North America CAR-T Cellular Immunotherapy Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe CAR-T Cellular Immunotherapy Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe CAR-T Cellular Immunotherapy Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe CAR-T Cellular Immunotherapy Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe CAR-T Cellular Immunotherapy Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe CAR-T Cellular Immunotherapy Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe CAR-T Cellular Immunotherapy Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Region (2021-2026) & (USD Million)
Table 51. South America CAR-T Cellular Immunotherapy Revenue by Type (2016-2021) & (USD Million)
Table 52. South America CAR-T Cellular Immunotherapy Revenue by Type (2021-2026) & (USD Million)
Table 53. South America CAR-T Cellular Immunotherapy Revenue by Application (2016-2021) & (USD Million)
Table 54. South America CAR-T Cellular Immunotherapy Revenue by Application (2021-2026) & (USD Million)
Table 55. South America CAR-T Cellular Immunotherapy Revenue by Country (2016-2021) & (USD Million)
Table 56. South America CAR-T Cellular Immunotherapy Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. CAR-T Cellular Immunotherapy Picture
Figure 2. Global CAR-T Cellular Immunotherapy Revenue Market Share by Type in 2020
Figure 3. Allogeneic
Figure 4. Autologous
Figure 5. CAR-T Cellular Immunotherapy Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Pharmacy Picture
Figure 8. Other Picture
Figure 9. Global CAR-T Cellular Immunotherapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global CAR-T Cellular Immunotherapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global CAR-T Cellular Immunotherapy Revenue Market Share by Region (2016-2026)
Figure 12. Global CAR-T Cellular Immunotherapy Revenue Market Share by Region in 2020
Figure 13. North America CAR-T Cellular Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe CAR-T Cellular Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific CAR-T Cellular Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America CAR-T Cellular Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa CAR-T Cellular Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. CAR-T Cellular Immunotherapy Market Drivers
Figure 19. CAR-T Cellular Immunotherapy Market Restraints
Figure 20. CAR-T Cellular Immunotherapy Market Trends
Figure 21. Fosun Kite Biotechnology Recent Developments and Future Plans
Figure 22. Gilead Sciences Recent Developments and Future Plans
Figure 23. Novartis Recent Developments and Future Plans
Figure 24. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 25. Global CAR-T Cellular Immunotherapy Revenue Share by Players in 2020
Figure 26. CAR-T Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 27. Global Top 3 Players CAR-T Cellular Immunotherapy Revenue Market Share in 2020
Figure 28. Global Top 10 Players CAR-T Cellular Immunotherapy Revenue Market Share in 2020
Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 30. Global CAR-T Cellular Immunotherapy Revenue Share by Type in 2020
Figure 31. Global CAR-T Cellular Immunotherapy Market Share Forecast by Type (2021-2026)
Figure 32. Global CAR-T Cellular Immunotherapy Revenue Share by Application in 2020
Figure 33. Global CAR-T Cellular Immunotherapy Market Share Forecast by Application (2021-2026)
Figure 34. North America CAR-T Cellular Immunotherapy Sales Market Share by Type (2016-2026)
Figure 35. North America CAR-T Cellular Immunotherapy Sales Market Share by Application (2016-2026)
Figure 36. North America CAR-T Cellular Immunotherapy Revenue Market Share by Country (2016-2026)
Figure 37. United States CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Canada CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Mexico CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Europe CAR-T Cellular Immunotherapy Sales Market Share by Type (2016-2026)
Figure 41. Europe CAR-T Cellular Immunotherapy Sales Market Share by Application (2016-2026)
Figure 42. Europe CAR-T Cellular Immunotherapy Revenue Market Share by Country (2016-2026)
Figure 43. Germany CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. France CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. United Kingdom CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Russia CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Italy CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Asia-Pacific CAR-T Cellular Immunotherapy Sales Market Share by Type (2016-2026)
Figure 49. Asia-Pacific CAR-T Cellular Immunotherapy Sales Market Share by Application (2016-2026)
Figure 50. Asia-Pacific CAR-T Cellular Immunotherapy Revenue Market Share by Region (2016-2026)
Figure 51. China CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Japan CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South Korea CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. India CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Southeast Asia CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Australia CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South America CAR-T Cellular Immunotherapy Sales Market Share by Type (2016-2026)
Figure 58. South America CAR-T Cellular Immunotherapy Sales Market Share by Application (2016-2026)
Figure 59. South America CAR-T Cellular Immunotherapy Revenue Market Share by Country (2016-2026)
Figure 60. Brazil CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Argentina CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Middle East and Africa CAR-T Cellular Immunotherapy Sales Market Share by Type (2016-2026)
Figure 63. Middle East and Africa CAR-T Cellular Immunotherapy Sales Market Share by Application (2016-2026)
Figure 64. Middle East and Africa CAR-T Cellular Immunotherapy Revenue Market Share by Country (2016-2026)
Figure 65. Turkey CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Saudi Arabia CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. UAE CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Methodology
Figure 69. Research Process and Data Source

Table of Contents

Related reports :

(Sep 21)

The Large Volume Parenteral (LVP) market report provides a detailed analysis of global market size, regional and country-level market size, ...

(Sep 21)

The Soy Isoflavones market report provides a detailed analysis of global market size, regional and country-level market size, segmentation m...

(Sep 21)

The Sevoflurane Source market report provides a detailed analysis of global market size, regional and country-level market size, segmentatio...

(Sep 21)

The Seaweed Powder market report provides a detailed analysis of global market size, regional and country-level market size, segmentation ma...

(Sep 21)

The Plasma Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation ma...

(Sep 21)

The Chromatography Reagents market report provides a detailed analysis of global market size, regional and country-level market size, segmen...

Global Info Research

GLOBAL CAR-T CELLULAR IMMUNOTHERAPY MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy